General
Preferred name
Mavacamten
Synonyms
MYK-461 ()
SAR439152 ()
MYK461 ()
Mavacamten (MYK-461) ()
Camzyos ()
SAR-439152 ()
P&D ID
PD060833
CAS
1642288-47-8
Tags
available
drug
Approved by
EMA
FDA
First approval
2022
Drug indication
Obstructive hypertrophic cardiomyopathy
hypertrophic cardiomyopathy
Drug Status
approved
investigational
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Mavacamten (MYK461) is an orally active modulator of cardiac myosin, with IC50s of 490, 711 nM for bovine cardiac and human cardiac, respectively.
PRICE 76
DESCRIPTION Mavacamten (MYK-461) is an orally active myosin allosteric modulator that was developed by MyoKardia as a novel treatment for obstructive hypertrophic cardiomyopathy (HCM). In 2020 MyoKardia was bought by Bristol Myers Squibb. The compound interacts with both α and β cardiac myosins in vitro. Preclinical pharmacokinetics are reported in . Mavacamten attenuates hypertrophic and profibrotic gene expression in rodent models of HCM . (GtoPdb)
DESCRIPTION Mavacamten (MYK-461) is an orally bioavailable inhibitor of cardiac myosin ATPase,( IC50s of 490, 711 nM for bovine cardiac and human cardiac, respectively) (TargetMol Bioactive Compound Library)
Cell lines
0
Organisms
1
Compound Sets
15
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
Guide to Pharmacology
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
46
Properties
(calculated by RDKit )
Molecular Weight
273.15
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
4
Ring Count
2
Aromatic Ring Count
2
cLogP
2.29
TPSA
66.89
Fraction CSP3
0.33
Chiral centers
1.0
Largest ring
6.0
QED
0.9
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
bovine cardiac
human cardiac
Myosin
Myosin inhibitor
MLCK
MOA
myosin inhibitor
Pathway
cytoskeleton
Cytoskeletal Signaling
Source data